Affinity Molecules

Executive Summary

Affinity Molecules is a San Diego-based biotechnology service provider specializing in custom stable cell line generation, protein and antibody production/purification, and biological assay development. Founded in 2018, the company supports research and therapeutic applications with a focus on quality and integrity, including mycoplasma detection services. As a pre-clinical stage company, Affinity Molecules serves as a critical partner for academic and industry researchers, offering tailored solutions to accelerate discovery and development. The contract service market for biologics is growing steadily, driven by demand for antibodies and recombinant proteins, providing a favorable environment for the company's expansion.

Upcoming Catalysts (preview)

• Q4 2026Launch of High-Throughput Antibody Production Service60% success
• Q2 2027Strategic Partnership with a Top 20 Pharma for Custom Cell Line Development30% success
• Q1 2027ISO 9001 Certification for Quality Management Systems70% success